Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 114
Filter
1.
Circulation ; 141(18): 1452-1462, 2020 05 05.
Article in English | MEDLINE | ID: mdl-32174130

ABSTRACT

BACKGROUND: The future risk of myocardial infarction is commonly assessed using cardiovascular risk scores, coronary artery calcium score, or coronary artery stenosis severity. We assessed whether noncalcified low-attenuation plaque burden on coronary CT angiography (CCTA) might be a better predictor of the future risk of myocardial infarction. METHODS: In a post hoc analysis of a multicenter randomized controlled trial of CCTA in patients with stable chest pain, we investigated the association between the future risk of fatal or nonfatal myocardial infarction and low-attenuation plaque burden (% plaque to vessel volume), cardiovascular risk score, coronary artery calcium score or obstructive coronary artery stenoses. RESULTS: In 1769 patients (56% male; 58±10 years) followed up for a median 4.7 (interquartile interval, 4.0-5.7) years, low-attenuation plaque burden correlated weakly with cardiovascular risk score (r=0.34; P<0.001), strongly with coronary artery calcium score (r=0.62; P<0.001), and very strongly with the severity of luminal coronary stenosis (area stenosis, r=0.83; P<0.001). Low-attenuation plaque burden (7.5% [4.8-9.2] versus 4.1% [0-6.8]; P<0.001), coronary artery calcium score (336 [62-1064] versus 19 [0-217] Agatston units; P<0.001), and the presence of obstructive coronary artery disease (54% versus 25%; P<0.001) were all higher in the 41 patients who had fatal or nonfatal myocardial infarction. Low-attenuation plaque burden was the strongest predictor of myocardial infarction (adjusted hazard ratio, 1.60 (95% CI, 1.10-2.34) per doubling; P=0.014), irrespective of cardiovascular risk score, coronary artery calcium score, or coronary artery area stenosis. Patients with low-attenuation plaque burden greater than 4% were nearly 5 times more likely to have subsequent myocardial infarction (hazard ratio, 4.65; 95% CI, 2.06-10.5; P<0.001). CONCLUSIONS: In patients presenting with stable chest pain, low-attenuation plaque burden is the strongest predictor of fatal or nonfatal myocardial infarction. These findings challenge the current perception of the supremacy of current classical risk predictors for myocardial infarction, including stenosis severity. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01149590.


Subject(s)
Angina, Stable/etiology , Computed Tomography Angiography , Coronary Angiography , Coronary Artery Disease/diagnostic imaging , Coronary Stenosis/diagnostic imaging , Myocardial Infarction/etiology , Plaque, Atherosclerotic , Vascular Calcification/diagnostic imaging , Aged , Angina, Stable/diagnosis , Angina, Stable/mortality , Coronary Artery Disease/complications , Coronary Artery Disease/mortality , Coronary Stenosis/complications , Coronary Stenosis/mortality , Female , Heart Disease Risk Factors , Humans , Male , Middle Aged , Myocardial Infarction/diagnosis , Myocardial Infarction/mortality , Predictive Value of Tests , Prognosis , Risk Assessment , Scotland , Time Factors , Vascular Calcification/complications , Vascular Calcification/mortality
2.
Crit Care Med ; 49(5): 804-815, 2021 05 01.
Article in English | MEDLINE | ID: mdl-33470780

ABSTRACT

OBJECTIVES: Severe coronavirus disease 2019 is associated with an extensive pneumonitis and frequent coagulopathy. We sought the true prevalence of thrombotic complications in critically ill patients with severe coronavirus disease 2019 on the ICU, with or without extracorporeal membrane oxygenation. DESIGN: We undertook a single-center, retrospective analysis of 72 critically ill patients with coronavirus disease 2019-associated acute respiratory distress syndrome admitted to ICU. CT angiography of the thorax, abdomen, and pelvis were performed at admission as per routine institution protocols, with further imaging as clinically indicated. The prevalence of thrombotic complications and the relationship with coagulation parameters, other biomarkers, and survival were evaluated. SETTING: Coronavirus disease 2019 ICUs at a specialist cardiorespiratory center. PATIENTS: Seventy-two consecutive patients with coronavirus disease 2019 admitted to ICU during the study period (March 19, 2020, to June 23, 2020). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: All but one patient received thromboprophylaxis or therapeutic anticoagulation. Among 72 patients (male:female = 74%; mean age: 52 ± 10; 35 on extracorporeal membrane oxygenation), there were 54 thrombotic complications in 42 patients (58%), comprising 34 pulmonary arterial (47%), 15 peripheral venous (21%), and five (7%) systemic arterial thromboses/end-organ embolic complications. In those with pulmonary arterial thromboses, 93% were identified incidentally on first screening CT with only 7% suspected clinically. Biomarkers of coagulation (e.g., d-dimer, fibrinogen level, and activated partial thromboplastin time) or inflammation (WBC count, C-reactive protein) did not discriminate between patients with or without thrombotic complications. Fifty-one patients (76%) survived to discharge; 17 (24%) patients died. Mortality was significantly greater in patients with detectable thrombus (33% vs 10%; p = 0.022). CONCLUSIONS: There is a high prevalence of thrombotic complications, mainly pulmonary, among coronavirus disease 2019 patients admitted to ICU, despite anticoagulation. Detection of thrombus was usually incidental, not predicted by coagulation or inflammatory biomarkers, and associated with increased risk of death. Systematic CT imaging at admission should be considered in all coronavirus disease 2019 patients requiring ICU.


Subject(s)
COVID-19/complications , COVID-19/diagnostic imaging , Computed Tomography Angiography , Critical Illness , Thrombosis/diagnostic imaging , Thrombosis/etiology , Adult , Aged , Female , Humans , Intensive Care Units , Length of Stay/statistics & numerical data , Male , Middle Aged , Mortality , Patient Discharge/statistics & numerical data , Prevalence , Retrospective Studies , SARS-CoV-2
3.
Emerg Infect Dis ; 25(1): 5-14, 2019 01.
Article in English | MEDLINE | ID: mdl-30431424

ABSTRACT

For >40 years, the British Royal Air Force has maintained an aeromedical evacuation facility, the Deployable Air Isolator Team (DAIT), to transport patients with possible or confirmed highly infectious diseases to the United Kingdom. Since 2012, the DAIT, a joint Department of Health and Ministry of Defence asset, has successfully transferred 1 case-patient with Crimean-Congo hemorrhagic fever, 5 case-patients with Ebola virus disease, and 5 case-patients with high-risk Ebola virus exposure. Currently, no UK-published guidelines exist on how to transfer such patients. Here we describe the DAIT procedures from collection at point of illness or exposure to delivery into a dedicated specialist center. We provide illustrations of the challenges faced and, where appropriate, the enhancements made to the process over time.


Subject(s)
Air Ambulances , Hemorrhagic Fever, Crimean/therapy , Hemorrhagic Fever, Ebola/therapy , Hemorrhagic Fevers, Viral/therapy , Patient Isolation/instrumentation , Patient Transfer/methods , Humans , Infection Control , Military Personnel , Patient Isolation/methods , Transportation of Patients , United Kingdom
4.
J Cardiovasc Magn Reson ; 21(1): 48, 2019 07 29.
Article in English | MEDLINE | ID: mdl-31352898

ABSTRACT

BACKGROUND: The benefit of cardiovascular magnetic resonance Imaging (CMR) in assessing occupational risk is unknown. Pilots undergo frequent medical assessment for occult disease, which threatens incapacitation or distraction during flight. ECG and examination anomalies often lead to lengthy restriction, pending full investigation. CMR provides a sensitive, specific assessment of cardiac anatomy, tissue characterisation, perfusion defects and myocardial viability. We sought to determine if CMR, when added to standard care, would alter occupational outcome. METHODS: A retrospective review was conducted of all personnel attending the RAF Aviation Medicine Consultation Service (AMCS) for assessment of a cardiac anomaly, over a 2-year period. Those undergoing standard of care (history, examination, exercise ECG, 24 h-Holter and transthoracic echocardiography), and those undergoing a CMR in addition, were identified. The influence of CMR upon the final decision regarding flying restriction was determined by comparing the diagnosis reached with standard of care plus CMR vs. standard of care alone. RESULTS: Of the ~ 8000 UK military aircrew, 558 personnel were seen for cardiovascular assessment. Fifty-two underwent CMR. A normal TTE did not reliably exclude abnormalities subsequently detected by CMR. Addition of CMR resulted in an upgraded occupational status in 62% of those investigated, with 37% returning to unrestricted duties. Only 8% of referrals were undiagnosed following CMR. All these were cases of borderline chamber dilatation and reduction in systolic function in whom diagnostic uncertainty remained between physiological exercise adaptation and early cardiomyopathy. CONCLUSIONS: CMR increases the likelihood of a definitive diagnosis and of return to flying. This study supports early use of CMR in occupational assessment for high-hazard occupations.


Subject(s)
Cardiovascular Diseases/diagnostic imaging , Magnetic Resonance Imaging , Military Personnel , Occupational Health , Pilots , Adult , Cardiovascular Diseases/pathology , Cardiovascular Diseases/physiopathology , Electrocardiography , Female , Health Status , Humans , Male , Middle Aged , Predictive Value of Tests , Reproducibility of Results , Retrospective Studies , Return to Work , Risk Assessment , Risk Factors , Time Factors , Workflow , Young Adult
5.
Pediatr Radiol ; 48(5): 632-637, 2018 05.
Article in English | MEDLINE | ID: mdl-29541807

ABSTRACT

BACKGROUND: Scimitar syndrome is a rare combination of cardiopulmonary abnormalities found in 1-3 per 1000 live births. Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is only found in 1 in 250-400 congenital heart disease patients. OBJECTIVE: We aimed to investigate the incidence of left circumflex ALCAPA within our referral center's cohort of scimitar syndrome patients. MATERIALS AND METHODS: A review of medical records, cardiac imaging and operative notes from all patients diagnosed with scimitar syndrome at our center between 1992 and 2016 was undertaken and all imaging reviewed. RESULTS: Fifty-four patients with scimitar syndrome and imaging were identified. Of these, 3 patients (1 male and 2 female) with ALCAPA were identified, representing an incidence of 5.5% (95% confidence interval [CI] 0-11.67%). In all three cases, the anomalous coronary arising from the pulmonary artery was the left circumflex coronary artery (LCx) and the point of origin was close to the pulmonary arterial bifurcation. CONCLUSION: We hypothesize that the prevalence of LCx-ALCAPA, in the setting of scimitar syndrome, may be greater than previously thought. We suggest that any patient with scimitar syndrome, especially with evidence of ischaemia, should be investigated for ALCAPA. Given its noninvasive nature and simultaneous imaging of the lungs, we suggest that cardiovascular CT is the most appropriate first-line investigation for these patients.


Subject(s)
Coronary Vessel Anomalies/diagnostic imaging , Coronary Vessel Anomalies/epidemiology , Pulmonary Artery/abnormalities , Scimitar Syndrome/diagnostic imaging , Scimitar Syndrome/epidemiology , Cardiac Catheterization , Coronary Angiography , Coronary Vessel Anomalies/surgery , Echocardiography , Electrocardiography , Fatal Outcome , Female , Humans , Incidence , Infant , Infant, Newborn , Male , Scimitar Syndrome/surgery , Tomography, X-Ray Computed
8.
Eur Radiol ; 26(5): 1493-502, 2016 May.
Article in English | MEDLINE | ID: mdl-26253256

ABSTRACT

OBJECTIVES: We validate a novel CT coronary angiography (CCTA) coronary calcium scoring system. METHODS: Calcium was quantified on CCTA images using a new patient-specific attenuation threshold: mean + 2SD of intra-coronary contrast density (HU). Using 335 patient data sets a conversion factor (CF) for predicting CACS from CCTA scores (CCTAS) was derived and validated in a separate cohort (n = 168). Bland-Altman analysis and weighted kappa for MESA centiles and Agatston risk groupings were calculated. RESULTS: Multivariable linear regression yielded a CF: CACS = (1.185 × CCTAS) + (0.002 × CCTAS × attenuation threshold). When applied to CCTA data sets there was excellent correlation (r = 0.95; p < 0.0001) and agreement (mean difference -10.4 [95% limits of agreement -258.9 to 238.1]) with traditional calcium scores. Agreement was better for calcium scores below 500; however, MESA percentile agreement was better for high risk patients. Risk stratification was excellent (Agatston groups k = 0.88 and MESA centiles k = 0.91). Eliminating the dedicated CACS scan decreased patient radiation exposure by approximately one-third. CONCLUSION: CCTA calcium scores can accurately predict CACS using a simple, individualized, semiautomated approach reducing acquisition time and radiation exposure when evaluating patients for CAD. This method is not affected by the ROI location, imaging protocol, or tube voltage strengthening its clinical applicability. KEY POINTS: • Coronary calcium scores can be reliably determined on contrast-enhanced cardiac CT • This score can accurately risk stratify patients • Elimination of a dedicated calcium scan reduces patient radiation by a third.


Subject(s)
Coronary Disease/diagnostic imaging , Vascular Calcification/diagnostic imaging , Aged , Coronary Angiography/methods , Coronary Vessels/diagnostic imaging , Feasibility Studies , Female , Humans , Male , Multidetector Computed Tomography/methods , Observer Variation , Radiation Dosage , Reproducibility of Results
19.
Aviat Space Environ Med ; 85(10): 1005-12, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25245900

ABSTRACT

BACKGROUND: Recent UK military operations in support of the fight against terrorism have resulted in UK military casualties. Movement of these casualties through the military medical chain requires a highly sophisticated aeromedical evacuation capability with worldwide reach. Recognition of the determinants of evacuation allows development to ensure optimal future configurations of military aeromedical evacuation services. METHODS: The database recording aeromedical evacuations undertaken by the Royal Air Force was searched to provide demographic and clinical data for evacuations between 1 April 2003 and 31 March 2010. Diagnoses leading to evacuation were categorized according to International Classification of Diseases codes. RESULTS: There were 21,477 medical evacuations undertaken. Analysis demonstrated 85.9% were for men and 86.5% were for military personnel, of whom 72.0% were in the army. The most common reasons for evacuation in military patients were musculoskeletal/connective tissue disorders (N = 9192; 50.0%), trauma (N = 1303; 7.1%), and mental health disorders (N = 1151; 6.3%). The most common reasons for evacuation in nonmilitary patients were musculoskeletal/connective tissue disorders (N = 734; 23.8%), genitourinary disorders (N = 325; 10.5%), and circulatory disorders (N = 255; 8.3%). Nontraumatic diagnoses were the determinants of evacuation in 92.9% of military and 95.1% of nonmilitary patients; 17.8% of trauma patients and 0.5% of nontrauma patients utilized high-dependency care. DISCUSSION: The UK aeromedical evacuation system must have the capacity to evacuate large numbers of patients with nontraumatic diagnoses, but also the flexibility to accommodate smaller, more variable numbers of higher dependency trauma patients. The military medical chain must continually review the differing requirements of civilian patients transferred within their aeromedical system.


Subject(s)
Aerospace Medicine , Aircraft , Military Personnel , Transportation of Patients , Connective Tissue Diseases/therapy , Female , Humans , Male , Mental Disorders/therapy , Musculoskeletal Diseases/therapy , United Kingdom , Urologic Diseases/therapy , Vascular Diseases/therapy , Warfare , Wounds and Injuries/therapy
20.
Int J Cardiol ; 395: 131594, 2024 Jan 15.
Article in English | MEDLINE | ID: mdl-37979795

ABSTRACT

BACKGROUND: Since the COVID-19 pandemic, post-COVID syndrome (persistent symptoms/complications lasting >12 weeks) continues to pose medical and economic challenges. In military personnel, where optimal fitness is crucial, prolonged limitations affecting their ability to perform duties has occupational and psychological implications, impacting deployability and retention. Research investigating post-COVID syndrome exercise capacity and cardiopulmonary effects in military personnel is limited. METHODS: UK military personnel were recruited from the Defence Medical Services COVID-19 Recovery Service. Participants were separated into healthy controls without prior SARS-CoV-2 infection (group one), and participants with prolonged symptoms (>12 weeks) after mild-moderate (community-treated) and severe (hospitalised) COVID-19 illness (group 2 and 3, respectively). Participants underwent cardiac magnetic resonance imaging (CMR) and spectroscopy, echocardiography, pulmonary function testing and cardiopulmonary exercise testing (CPET). RESULTS: 113 participants were recruited. When compared in ordered groups (one to three), CPET showed stepwise decreases in peak work, work at VT1 and VO2 max (all p < 0.01). There were stepwise decreases in FVC (p = 0.002), FEV1 (p = 0.005), TLC (p = 0.002), VA (p < 0.001), and DLCO (p < 0.002), and a stepwise increase in A-a gradient (p < 0.001). CMR showed stepwise decreases in LV/RV volumes, stroke volumes and LV mass (LVEDVi/RVEDVi p < 0.001; LVSV p = 0.003; RVSV p = 0.001; LV mass index p = 0.049). CONCLUSION: In an active military population, post-COVID syndrome is linked to subclinical changes in maximal exercise capacity. Alongside disease specific changes, many of these findings share the phenotype of deconditioning following prolonged illness or bedrest. Partitioning of the relative contribution of pathological changes from COVID-19 and deconditioning is challenging in post-COVID syndrome recovery.


Subject(s)
COVID-19 , Military Personnel , Humans , Exercise Tolerance , Pandemics , SARS-CoV-2 , Lung , Exercise Test
SELECTION OF CITATIONS
SEARCH DETAIL